Patent: 6,599,873
✉ Email this page to a colleague
Summary for Patent: 6,599,873
Title: | Interleukin-1 inhibitors, compositions, and methods of treatment |
Abstract: | Interleukin-1 inhibitors are provided. Compositions comprising an interleukin-1 inhibitor are provided. Methods of treating a patient comprising administering an interleukin-1 inhibitor are provided. |
Inventor(s): | Sommer; Andreas (Concord, CA), Hannum; Charles H. (Boulder, CO), Eisenburg; Stephen P. (Boulder, CO), Thompson; Robert C. (Boulder, CO), Arend; William P. (Denver, CO), Joslin; Fenneke G. (Denver, CO) |
Assignee: | Amgen Inc. (Thousand Oaks, CA) The Regents of the University of Colorado (Boulder, CO) |
Application Number: | 08/468,425 |
Patent Claims: | see list of patent claims |
Details for Patent 6,599,873
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Smith & Nephew, Inc. | SANTYL | collagenase | Ointment | 101995 | June 04, 1965 | ⤷ Sign Up | 2020-07-29 |
Swedish Orphan Biovitrum Ab (publ) | KINERET | anakinra | Injection | 103950 | November 14, 2001 | ⤷ Sign Up | 2020-07-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 6,599,873
Country | Patent Number | Estimated Expiration |
---|---|---|
Austria | E162801 | ⤷ Sign Up |
Austria | E215966 | ⤷ Sign Up |
Austria | E240740 | ⤷ Sign Up |
Austria | E88502 | ⤷ Sign Up |
Australia | 1674292 | ⤷ Sign Up |
Australia | 2828695 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |